Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,446 | 301 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $888.49 | 77 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $572.41 | 41 | $0 (2024) |
| ITI, Inc. | $533.41 | 33 | $0 (2023) |
| Lundbeck LLC | $446.42 | 28 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $371.88 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $340.68 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $267.88 | 16 | $0 (2022) |
| Axsome Therapeutics, Inc. | $183.47 | 10 | $0 (2024) |
| Alkermes, Inc. | $177.03 | 11 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $170.74 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $886.91 | 52 | Janssen Pharmaceuticals, Inc ($166.20) |
| 2023 | $1,306 | 88 | ABBVIE INC. ($283.57) |
| 2022 | $1,310 | 91 | ABBVIE INC. ($327.94) |
| 2021 | $943.68 | 70 | AbbVie Inc. ($229.14) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Neuroscience | ||||||
| 11/25/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: OUD | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/08/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Neuroscience | ||||||
| 10/28/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: OUD | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neurology | ||||||
| 09/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Neuroscience | ||||||
| 09/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Neurology | ||||||
| 09/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/21/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: OUD | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Neuroscience | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Central Nervous System | ||||||
| 07/31/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Neurology | ||||||
| 07/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: OUD | ||||||
| 06/24/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: BH | ||||||
| 06/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 276 | 577 | $117,296 | $30,134 |
| 2022 | 7 | 244 | 493 | $84,694 | $25,432 |
| 2021 | 7 | 217 | 541 | $86,734 | $26,818 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 126 | 284 | $62,480 | $14,995 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 134 | $29,480 | $8,193 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 51 | $7,734 | $2,520 | 32.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 45 | $8,360 | $2,216 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 40 | 45 | $6,750 | $1,696 | 25.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 13 | 18 | $2,492 | $514.69 | 20.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 180 | $26,280 | $8,000 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 69 | 103 | $22,312 | $6,290 | 28.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 31 | 32 | $8,616 | $3,633 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 54 | 92 | $13,260 | $3,229 | 24.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 21 | 52 | $7,124 | $2,056 | 28.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 20 | $4,260 | $1,337 | 31.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 14 | $2,842 | $886.84 | 31.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 302 | $44,092 | $13,649 | 31.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 42 | 104 | $14,976 | $4,254 | 28.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 30 | 30 | $7,920 | $3,115 | 39.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 33 | 36 | $7,308 | $2,202 | 30.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 21 | 24 | $5,112 | $1,640 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 27 | $5,778 | $1,640 | 28.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 12 | 18 | $1,548 | $318.62 | 20.6% |
About Michael Gerber
Michael Gerber is a Family healthcare provider based in Mason City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1639607757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Gerber has received a total of $4,446 in payments from pharmaceutical and medical device companies, with $886.91 received in 2024. These payments were reported across 301 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,446).
As a Medicare-enrolled provider, Gerber has provided services to 737 Medicare beneficiaries, totaling 1,611 services with total Medicare billing of $82,385. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health, Psychiatric/Mental Health
- Location Mason City, IA
- Active Since 06/02/2017
- Last Updated 10/28/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1639607757
Products in Payments
- VRAYLAR (Drug) $888.49
- CAPLYTA (Drug) $634.00
- REXULTI (Drug) $592.51
- SPRAVATO (Drug) $398.55
- LATUDA (Drug) $267.88
- Auvelity (Drug) $183.47
- Austedo XR (Drug) $177.93
- ARISTADA (Drug) $177.03
- INVEGA SUSTENNA (Drug) $173.86
- ABILIFY MAINTENA (Drug) $166.67
- UZEDY (Drug) $130.31
- HETLIOZ (Drug) $94.60
- PERSERIS (Drug) $89.85
- INGREZZA (Drug) $88.87
- FANAPT (Drug) $76.14
- SUBLOCADE (Drug) $67.31
- JORNAY PM (Drug) $65.53
- AUSTEDO (Drug) $63.64
- BRINTELLIX (Drug) $27.92
- WAKIX (Drug) $18.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Mason City
Kaci Younger, Fnp-C, FNP-C
Family — Payments: $3,409
Krishna Hughes, Arnp, ARNP
Family — Payments: $2,868
Dr. Luke Hachfeld, Dnp, Fnp-Bc, Arnp, DNP, FNP-BC, ARNP
Family — Payments: $1,846
Ellen Hendricks, Apn, APN
Family — Payments: $948.76
Kelli Badker, Arnp, ARNP
Family — Payments: $888.83
Paige Burtness, Fnp-C, FNP-C
Family — Payments: $714.02